Behovet blev bedømt af den behandlende læge ud fra sygdomsaktivitet og uanset det perifere B lymfocyttal.
Patients received subsequent courses of MabThera as needed according to the treating clinician’ s assessment of disease activity and irrespective of the peripheral B lymphocyte count.